OMA Guidelines Bundle

Obesity-Related Diseases - Obesity Algorithm 2024

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1349827

Contents of this Issue

Navigation

Page 21 of 23

22 Disease Categories Reducing Cancer Risk   ➤ Intentional weight loss among patients with excess adiposity reduces the risk of cancer via decreased inflammation, oxidative stress, and cellular DNA damage.   ➤ In patients with obesity and cancer, weight loss is associated with decreased cancer cell proliferation, enhanced cancer cell death, and enhanced response to cancer treatment.   ➤ In general, besides the Mediterranean diet, the effect of dietary patterns has not been widely studied. • The Mediterranean diet has been associated with a decreased risk of colorectal, breast, gastric, prostate, liver, and head and neck cancer.   ➤ Foods containing phytochemicals, fiber, and antioxidants can potentially reduce the risk of cancer. • Examples of these include f ruits, vegetables, nuts, and other plant- based foods. • Antioxidants may be most benef icial when obtained f rom healthful food, compared to vitamin pills or other supplements.   ➤ In general, the addition to physical activity of medical nutrition therapy reduces cancer-related inflammatory and hormonal biomarkers, thereby reducing the risk of cancer incidence.   ➤ In patients with cancer, physical activity: • Reduces the risk of cancer recurrence. • Inhibits cancer cell proliferation. • Increases cancer cell apoptosis. • Favorably affects inflammation, immune response, and cancer metabolism. • Enhances effectiveness of cancer treatment. • Counteracts cancer and cancer treatment-related complications.   ➤ The effect of weight loss interventions with anti-obesity medications on cancer risk has not been evaluated. • Notably, GLP-1 analogues are used for the treatment of overweight and obesity and have been associated with thyroid C-cell proliferation in animal models. • However, a meta-analysis concluded that there was no signif icant effect on thyroid cancer risk in patients receiving GLP-1 analogs.

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity-Related Diseases - Obesity Algorithm 2024